Turning Point Therapeutics, Inc. Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Turning Point Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Turning Point Therapeutics, Inc. for April 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2019 | TPTX | Turning Point Ther ... | Cormorant Asset Management, LP | 10% Owner | Buy | P | 18.00 | 400,000 | 7,200,000 | 3,099,099 | 2.7 M to 3.1 M (+14.82 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Buy | P | 18.00 | 325,000 | 5,850,000 | 1,992,550 | 1.7 M to 2 M (+19.49 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 360,000 | 6,480,000 | 2,027,550 | 1.7 M to 2 M (+21.59 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Buy | P | 18.00 | 60,000 | 1,080,000 | 1,727,550 | 1.7 M to 1.7 M (+3.60 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Lu Hongbo | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Gujrathi Sheila | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | P | 18.00 | 360,000 | 6,480,000 | 2,027,550 | 1.7 M to 2 M (+21.59 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | P | 18.00 | 325,000 | 5,850,000 | 1,992,550 | 1.7 M to 2 M (+19.49 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Chacko Jacob | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Baker Brian Lee | VP of Finance and A ... | Buy | P | 18.00 | 2,800 | 50,400 | 2,800 | 0 to 2.8 K |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | P | 18.00 | 12,000 | 216,000 | 12,000 | 0 to 12 K |